These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6518769)

  • 1. Designs for group sequential tests.
    Fleming TR; Harrington DP; O'Brien PC
    Control Clin Trials; 1984 Dec; 5(4):348-61. PubMed ID: 6518769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptive Designs with Discrete Test Statistics and Consideration of Overrunning.
    Schmidt R; Burkhardt B; Faldum A
    Methods Inf Med; 2015; 54(5):434-46. PubMed ID: 26429500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robust inference for group sequential trials.
    Ganju J; Lin Y; Zhou K
    Pharm Stat; 2017 Mar; 16(2):167-173. PubMed ID: 28133895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Termination rules in therapeutic trials. Application of sequential methods in 2 clinical trials in hematology].
    Bénichou J; Lepage E; Chastang C
    Nouv Rev Fr Hematol (1978); 1987; 29(1):87-91. PubMed ID: 3473443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Information time scales for interim analyses of randomized clinical trials.
    Freidlin B; Othus M; Korn EL
    Clin Trials; 2016 Aug; 13(4):391-9. PubMed ID: 27136947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ; Lipsky AM; Berry DA
    Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symmetric group sequential test designs.
    Emerson SS; Fleming TR
    Biometrics; 1989 Sep; 45(3):905-23. PubMed ID: 2675998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Planned interim analysis and its role in cancer clinical trials.
    Geller NL
    J Clin Oncol; 1987 Sep; 5(9):1485-90. PubMed ID: 3625263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Group sequential t-test for clinical trials with small sample sizes across stages.
    Shao J; Feng H
    Contemp Clin Trials; 2007 Sep; 28(5):563-71. PubMed ID: 17434814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-designing trial combined with classical group sequential monitoring.
    Yin G; Shen Y
    J Biopharm Stat; 2005; 15(4):667-75. PubMed ID: 16022171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the use of randomization tests following adaptive designs.
    Galbete A; Rosenberger WF
    J Biopharm Stat; 2016; 26(3):466-74. PubMed ID: 26043105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Power comparisons for group sequential tests with nonparametric statistics in case of nonproportional hazards.
    Demirhan H; Demirhan YP; Bacanli S
    J Biopharm Stat; 2013 Mar; 23(2):447-60. PubMed ID: 23437950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Group sequential designs with robust semiparametric recurrent event models.
    Mütze T; Glimm E; Schmidli H; Friede T
    Stat Methods Med Res; 2019 Aug; 28(8):2385-2403. PubMed ID: 29890892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptive allocation in randomized controlled trials.
    Birkett NJ
    Control Clin Trials; 1985 Jun; 6(2):146-55. PubMed ID: 4006488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of data arising from a stratified design with the cluster as unit of randomization.
    Donner A; Donald A
    Stat Med; 1987; 6(1):43-52. PubMed ID: 3576016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General statistical design considerations of randomized clinical trials.
    Peduzzi P
    Prog Clin Biol Res; 1988; 264():61-70. PubMed ID: 3289035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditional power calculations for early acceptance of H0 embedded in sequential tests.
    Betensky RA
    Stat Med; 1997 Feb; 16(4):465-77. PubMed ID: 9044533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early termination of clinical trials with prolonged observation of individual patients: a case study.
    van Es GA; Tijssen JG; Lubsen J; van Strik R
    Stat Med; 1987 Dec; 6(8):927-37. PubMed ID: 3438618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Size of cancer clinical trials and stopping rules.
    Pocock SJ
    Br J Cancer; 1978 Dec; 38(6):757-66. PubMed ID: 369589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sample size adjustment designs with time-to-event outcomes: A caution.
    Freidlin B; Korn EL
    Clin Trials; 2017 Dec; 14(6):597-604. PubMed ID: 28795844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.